This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of securing 8(a) sole source contracts with the FDA to provide a wide range of professional services across multiple centers and offices, including medical and scientific writing, administrative support, information technology, quality assurance, database administration, and technical support.
Generated 3/6/25, 10:18 AM